Industrial collaborations

The AIBN is an IP-rich environment with innovative technologies, cutting edge capabilities, acknowledged research leaders and a culture of collaboration. It adds value through the research and development of new processes, technologies, materials and devices in the following areas:

  • Nanotechnology-based imaging and drug delivery for therapeutic products;
  • Regenerative medicine: biology, stem cells, micro-bioreactors and novel scaffolds;
  • Nanotechnology enabled commodity products for industrial application;
  • Novel protein expression utilising metabolomics and systems biotechnology; and
  • Nanotechnology for energy and environmental applications
  • Bioprocessing and small-scale manufacture of biologics
  • Advanced cell culture facilities
  • Nanoparticle production and analysis capabilities
  • Polymer synthesis and characterisation
  • Microanalysis
  • Ultra-high performance flow cytometry.

AIBN is ready, willing and able to work for, or with, industry. The Institute can undertake R&D with flexible arrangements to meet partner’s needs, including:

  • Consulting;
  • Partnering;
  • Contract research;
  • Licensing; or
  • Investment in the formation of a start-up company.

For speculative, strategic or long-term corporate initiatives, it is also possible to sponsor postgraduate research students to explore new areas of research.

Click here for contact details of AIBN's I&CD team